GASTROINTESTINAL CANCER RESEARCH

Understanding predisposition to cancer of the oesophagus through inherited defects in DNA

Dr Lauren Aoude

Dr Lauren Aoude

Dr Lauren’s 2023 grant is funded by Cure Cancer

She was also funded by Cure Cancer in 2019.

Dr Lauren is a UQ Amplify Fellow in the Surgical Oncology Group at The University of Queensland Frazer Institute.

Dr Lauren Aoude completed a PhD in melanoma genetics at The University of Queensland in 2014. During her PhD, she was involved in whole-genome/exome sequencing of over 250 melanoma families. In 2016, she was awarded an NHMRC Early Career Fellowship to investigate precision medicine for the treatment of metastatic melanoma. Her current project investigates which genes increase the likelihood of a patient developing oesophageal adenocarcinoma (OAC).

Dr Lauren Aoude's research

The incidence of OAC in Australia has more than doubled in the past three decades, but currently the outlook for patients is poor, with few treatment options available. Dr Lauren Aoude and her team are committed to changing this. 

Up to 10% of all cancers are caused by inherited DNA mutations. Knowledge of these mutations are extremely useful in understanding a patients risk of developing specific cancers, and also personalising treatment to improve outcomes. While we know of these mutations for many cancers, we have not yet identified any that are associated with OAC. 

Dr Lauren’s research aims to identify these genes through genome sequencing. Understanding these pathways will allow clinicians to have a better understanding of who is most at risk of developing OAC; improve screening and early detection; better predict treatment responses; and ultimately improve health outcomes for patients.  

“This project will create important advances in the understanding of OAC development. The knowledge gained will enable earlier detection of cancer and improved screening which increases the chances for successful treatment.”

The importance of cancer research funding

“The greatest hurdle for early-career researchers is the ability to secure long term funding,” says Dr Lauren.

“The funding landscape in Australia is incredibly competitive. As an early-career researcher myself, this Cure Cancer grant means so much to my career progression. Emerging researchers bring renewed energy to the field and innovative ideas that are vital if we are going to make a difference to the lives of cancer patients.”

“Cure Cancer has provided me with the opportunity to lead my project and follow my dreams. I aspire to lead my own lab in the future and having this support is a step on that path. I truly believe this project that could have a positive impact for patients with oesophageal cancer.”

“Cancer touches the lives of so many. Research in this area has enabled the development of new treatments that have significantly improved outcomes for patients and their families.  I am privileged to play a part in that.”

Together, we can cure cancer.

Related Blog posts

In the media

Dr Kulasinghe named Researcher of the Year

Early-career researchers boosted in mission to beat cancer

Cure Cancer Opens Early-Career Research Grant Applications For 2023

Lunch & Learn series

Find out about the latest developments in cancer research first hand from our researchers and the impact of your support.

We take on every cancer

Cure Cancer funds ground breaking research across every cancer, no matter the size or rarity.

We aim to maximise our impact, save millions of lives, and leaves no one behind.

Blood Cancer

Bone Cancer

Brain Cancer

Breast Cancer

Childhood Cancer

Gastro-Intestinal Cancer

Gynaecological Cancer

Prostate Cancer

Our research grant program

We are dedicated to funding new innovative cancer research projects, giving talented emerging cancer researchers the opportunity to pursue their innovative ideas across diverse areas of cancer research.

Through our Research Grants Program, we commit to back new ideas from the most brilliant minds in cancer research.

Let's stay in touch

To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.